Diabetes, Vol 42, Issue 6 933-936, Copyright © 1993 by American Diabetes Association

ARTICLES

Kinetics of proinsulin conversion in human islets

S Sizonenko, JC Irminger, L Buhler, S Deng, P Morel and PA Halban
Laboratoires de Recherche Louis Jeantet, Centre Medical Universitaire, Geneva, Switzerland.

Islets isolated from human cadaver pancreas were pulse-labeled (10 min with [3H]leucine) and then incubated for a 180-min chase. Islets and chase medium were collected every 15 min and analyzed by reversed-phase HPLC to quantify the percentage of radioactively labeled proinsulin, conversion intermediates, and fully processed insulin. Release of proinsulin-related labeled products into the chase medium was < 10% of total. Whereas 50% of labeled proinsulin had been lost by conversion within 45 min, fully processed insulin only appeared with a half-time of 100 min. This discrepancy is attributable to accumulation of radioactive conversion intermediates. Des 64.65 split proinsulin was a minor component, reaching a maximum of 5.2 +/- 1.7% (n = 4) at 60 min of chase. By contrast, des 31.32 split proinsulin--and a truncated form lacking the first three residues of C-peptide--rose progressively to 29.3 +/- 1.4% by 75 min, and declined thereafter. The accumulation of des 31.32 split proinsulin rather than the des 64.65 split form during the conversion of human proinsulin reflects slower conversion at the C-peptide/A-chain than at the B-chain/C-peptide junction, and is consistent with the appearance of this particular conversion intermediate in the circulation.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Marzban, G. Trigo-Gonzalez, and C. B. Verchere Processing of Pro-Islet Amyloid Polypeptide in the Constitutive and Regulated Secretory Pathways of {beta} Cells Mol. Endocrinol., August 1, 2005; 19(8): 2154 - 2163. [Abstract] [Full Text] [PDF]

				P. A. Halban and J.-C. Irminger Mutant Proinsulin That Cannot Be Converted Is Secreted Efficiently from Primary Rat beta -Cells via the Regulated Pathway Mol. Biol. Cell, March 1, 2003; 14(3): 1195 - 1203. [Abstract] [Full Text] [PDF]

				S. E. Kahn The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058. [Full Text] [PDF]

				R. Kuliawat, D. Prabakaran, and P. Arvan Proinsulin Endoproteolysis Confers Enhanced Targeting of Processed Insulin to the Regulated Secretory Pathway Mol. Biol. Cell, June 1, 2000; 11(6): 1959 - 1972. [Abstract] [Full Text]

				M. Deberg, P. Houssa, B. H. Frank, F. Sodoyez-Goffaux, and J.-C. Sodoyez Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors Clin. Chem., July 1, 1998; 44(7): 1504 - 1513. [Abstract] [Full Text] [PDF]

				Y. Zambre, Z. Ling, X. Hou, A. Foriers, B. Van Den Bogaert, C. Van Schravendijk, and D. Pipeleers Effect of Glucose on Production and Release of Proinsulin Conversion Products by Cultured Human Islets J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1234 - 1238. [Abstract] [Full Text]

				M. Furuta, R. Carroll, S. Martin, H. H. Swift, M. Ravazzola, L. Orci, and D. F. Steiner Incomplete Processing of Proinsulin to Insulin Accompanied by Elevation of Des-31,32 Proinsulin Intermediates in Islets of Mice Lacking Active PC2 J. Biol. Chem., February 6, 1998; 273(6): 3431 - 3437. [Abstract] [Full Text] [PDF]

				A. D. Kippen, F. Cerini, L. Vadas, R. Stocklin, L. Vu, R. E. Offord, and K. Rose Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay J. Biol. Chem., May 9, 1997; 272(19): 12513 - 12522. [Abstract] [Full Text] [PDF]